Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Revenue

Silco Pharmaceuticals had revenue of 116.05M BDT in the quarter ending September 30, 2025, with 5.53% growth. In the fiscal year ending June 30, 2024, Silco Pharmaceuticals had annual revenue of 410.10M, down -11.75%.

• Revenue: 410.10M
• Revenue Growth: -11.75%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 313
• Market Cap: 1.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	410.10M	-54.59M	-11.75%
Jun 30, 2023	464.70M	-94.77M	-16.94%
Jun 30, 2022	559.47M	-41.59M	-6.92%
Jun 30, 2021	601.06M	-132.59M	-18.07%
Jun 30, 2020	733.65M	-185.39M	-20.17%